EP1839658A1 — Pharmaceutical composition comprising micronized nebivolol
Assigned to Sandoz AS · Expires 2007-10-03 · 19y expired
What this patent protects
The present invention relates to a solid pharmaceutical composition, which comprises micronized Nebivolol or a pharmaceutically acceptable micronized acid addition salt thereof as the active agent, a filler, a disintegrant, a binding agent and a lubricant. The dissolution of said…
USPTO Abstract
The present invention relates to a solid pharmaceutical composition, which comprises micronized Nebivolol or a pharmaceutically acceptable micronized acid addition salt thereof as the active agent, a filler, a disintegrant, a binding agent and a lubricant. The dissolution of said solid composition is at least 75 % after 45 minutes even though no wetting agent is present in the composition. The present invention also relates to a method for the manufacture of a tablet, which comprises the pharmaceutical composition and uses thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.